{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:01:20Z","timestamp":1780092080398,"version":"3.54.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T00:00:00Z","timestamp":1656806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T00:00:00Z","timestamp":1656806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00415-022-11248-y","type":"journal-article","created":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T19:32:00Z","timestamp":1656876720000},"page":"5893-5900","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Guillain\u2013Barr\u00e9-like syndrome: an uncommon feature of CASPR2 and LGI1 autoimmunity"],"prefix":"10.1007","volume":"269","author":[{"given":"Xiaoping","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,3]]},"reference":[{"issue":"9","key":"11248_CR1","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain 133(9):2734\u20132748","journal-title":"Brain"},{"issue":"2","key":"11248_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.23577","volume":"72","author":"SR Irani","year":"2012","unstructured":"Irani SR, Pettingill P, Kleopa KA et al (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72(2):241\u2013255","journal-title":"Ann Neurol"},{"issue":"Pt 12","key":"11248_CR3","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","volume":"124","author":"R Liguori","year":"2001","unstructured":"Liguori R, Vincent A, Clover L et al (2001) Morvan\u2019s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 124(Pt 12):2417\u20132426","journal-title":"Brain"},{"issue":"4","key":"11248_CR4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00415-019-09686-2","volume":"267","author":"M Boyko","year":"2020","unstructured":"Boyko M, Au KLK, Casault C, de Robles P, Pfeffer G (2020) Systematic review of the clinical spectrum of CASPR2 antibody syndrome. J Neurol 267(4):1137\u20131146","journal-title":"J Neurol"},{"issue":"1","key":"11248_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jnnp-2016-315480","volume":"89","author":"J Fehmi","year":"2018","unstructured":"Fehmi J, Scherer SS, Willison HJ, Rinaldi S (2018) Nodes, paranodes and neuropathies. J Neurol Neurosurg Psychiatry 89(1):61\u201371","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"11248_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","volume":"17","author":"JJ Devaux","year":"2012","unstructured":"Devaux JJ, Odaka M, Yuki N (2012) Nodal proteins are target antigens in Guillain\u2013Barre syndrome. J Peripher Nerv Syst 17(1):62\u201371","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"11248_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/jns.12089","volume":"19","author":"RE Rosch","year":"2014","unstructured":"Rosch RE, Bamford A, Hacohen Y et al (2014) Guillain\u2013Barre syndrome associated with CASPR2 antibodies: two paediatric cases. J Peripher Nerv Syst 19(3):246\u2013249","journal-title":"J Peripher Nerv Syst"},{"issue":"5","key":"11248_CR8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/mus.23851","volume":"48","author":"E Tuzun","year":"2013","unstructured":"Tuzun E, Kinay D, Hacohen Y, Aysal F, Vincent A (2013) Guillain\u2013Barre-like syndrome associated with lung adenocarcinoma and CASPR2 antibodies. Muscle Nerve 48(5):836\u2013837","journal-title":"Muscle Nerve"},{"issue":"4","key":"11248_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jnnp-2016-314758","volume":"88","author":"B Lang","year":"2017","unstructured":"Lang B, Makuch M, Moloney T et al (2017) Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies. J Neurol Neurosurg Psychiatry 88(4):353\u2013361","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"11248_CR10","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/j.1468-1331.2010.02993.x","volume":"17","author":"E Tuzun","year":"2010","unstructured":"Tuzun E, Kurtuncu M, Lang B et al (2010) Bickerstaff\u2019s encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies. Eur J Neurol 17(10):1304\u20131307","journal-title":"Eur J Neurol"},{"issue":"6","key":"11248_CR11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1083\/jcb.200305078","volume":"162","author":"M Traka","year":"2003","unstructured":"Traka M, Goutebroze L, Denisenko N et al (2003) Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J Cell Biol 162(6):1161\u20131172","journal-title":"J Cell Biol"},{"issue":"6","key":"11248_CR12","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1083\/jcb.200305018","volume":"162","author":"S Poliak","year":"2003","unstructured":"Poliak S, Salomon D, Elhanany H et al (2003) Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol 162(6):1149\u20131160","journal-title":"J Cell Biol"},{"issue":"5","key":"11248_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","volume":"13","author":"A van Sonderen","year":"2017","unstructured":"van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ (2017) The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol 13(5):290\u2013301","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"11248_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","volume":"87","author":"A van Sonderen","year":"2016","unstructured":"van Sonderen A, Arino H, Petit-Pedrol M et al (2016) The clinical spectrum of Caspr2 antibody-associated disease. Neurology 87(5):521\u2013528","journal-title":"Neurology"},{"issue":"6 Pt 2","key":"11248_CR15","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/j.lpm.2013.01.058","volume":"42","author":"MC Dalakas","year":"2013","unstructured":"Dalakas MC (2013) Pathophysiology of autoimmune polyneuropathies. Presse Med 42(6 Pt 2):e181-192","journal-title":"Presse Med"},{"issue":"4","key":"11248_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/mus.25371","volume":"55","author":"R Lahoria","year":"2017","unstructured":"Lahoria R, Pittock SJ, Gadoth A, Engelstad JK, Lennon VA, Klein CJ (2017) Clinical-pathologic correlations in voltage-gated Kv1 potassium channel complex-subtyped autoimmune painful polyneuropathy. Muscle Nerve 55(4):520\u2013525","journal-title":"Muscle Nerve"},{"issue":"6","key":"11248_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.7150\/ijbs.4.387","volume":"4","author":"K Sagane","year":"2008","unstructured":"Sagane K, Ishihama Y, Sugimoto H (2008) LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11. Int J Biol Sci 4(6):387\u2013396","journal-title":"Int J Biol Sci"},{"issue":"10","key":"11248_CR18","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/nm.2019","volume":"15","author":"YD Zhou","year":"2009","unstructured":"Zhou YD, Lee S, Jin Z, Wright M, Smith SE, Anderson MP (2009) Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med 15(10):1208\u20131214","journal-title":"Nat Med"},{"key":"11248_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jocn.2015.06.025","volume":"25","author":"I Lotan","year":"2016","unstructured":"Lotan I, Djaldetti R, Hellman MA, Benninger F (2016) Atypical case of Morvan\u2019s syndrome. J Clin Neurosci 25:132\u2013134","journal-title":"J Clin Neurosci"},{"issue":"1","key":"11248_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24979","volume":"82","author":"A Gadoth","year":"2017","unstructured":"Gadoth A, Pittock SJ, Dubey D et al (2017) Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients. Ann Neurol 82(1):79\u201392","journal-title":"Ann Neurol"},{"issue":"8","key":"11248_CR21","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/ene.12758","volume":"22","author":"MG Huijbers","year":"2015","unstructured":"Huijbers MG, Querol LA, Niks EH et al (2015) The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol 22(8):1151\u20131161","journal-title":"Eur J Neurol"},{"issue":"10","key":"11248_CR22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","volume":"82","author":"L Querol","year":"2014","unstructured":"Querol L, Nogales-Gadea G, Rojas-Garcia R et al (2014) Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology 82(10):879\u2013886","journal-title":"Neurology"},{"issue":"10","key":"11248_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102646","volume":"19","author":"I Koneczny","year":"2020","unstructured":"Koneczny I (2020) Update on IgG4-mediated autoimmune diseases: new insights and new family members. Autoimmun Rev 19(10):102646","journal-title":"Autoimmun Rev"},{"issue":"2","key":"11248_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrneurol.2014.253","volume":"11","author":"JD Lunemann","year":"2015","unstructured":"Lunemann JD, Nimmerjahn F, Dalakas MC (2015) Intravenous immunoglobulin in neurology\u2014mode of action and clinical efficacy. Nat Rev Neurol 11(2):80\u201389","journal-title":"Nat Rev Neurol"},{"key":"11248_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.815976","volume":"10","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Tan C, Li T et al (2022) Phenotypic spectrum of CASPR2 and LGI1 antibodies associated neurological disorders in children. Front Pediatr 10:815976","journal-title":"Front Pediatr"},{"key":"11248_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106187","volume":"197","author":"Y Jia","year":"2020","unstructured":"Jia Y, Shi H, Ye J, Wang Y (2020) Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies. Clin Neurol Neurosurg 197:106187","journal-title":"Clin Neurol Neurosurg"},{"issue":"12","key":"11248_CR27","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1007\/s00415-021-10614-6","volume":"268","author":"MA Kilic","year":"2021","unstructured":"Kilic MA, Yoruk Yildirim ZN, Oner A et al (2021) Pediatric LGI1 and CASPR2 autoimmunity associated with COVID 19: Morvan syndrome. J Neurol 268(12):4492\u20134494","journal-title":"J Neurol"},{"issue":"2","key":"11248_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.22297","volume":"69","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Huijbers MG, Bar V et al (2011) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69(2):303\u2013311","journal-title":"Ann Neurol"},{"issue":"4","key":"11248_CR29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neurol.2020.07.009","volume":"177","author":"S Maldonado-Slootjes","year":"2021","unstructured":"Maldonado-Slootjes S, Smetcoren C, Pieret F, Gille M (2021) An unusual association of chronic inflammatory demyelinating polyneuropathy and anti-contactin-associated protein 2 (CASPR2) syndrome. Rev Neurol (Paris) 177(4):431\u2013433","journal-title":"Rev Neurol (Paris)"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11248-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11248-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11248-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T12:05:16Z","timestamp":1665489916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11248-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,3]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["11248"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11248-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,3]]},"assertion":[{"value":"6 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the local Institutional Review Board and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Informed consent was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}